PO.TB09.01 · 肿瘤生物学

整合克隆和单细胞分析揭示早期子宫内膜样子宫内膜癌中祖细胞驱动的肿瘤多样化

Integrated clonal and single-cell analyses uncover progenitor-driven tumor diversification in early-stage endometrioid endometrial carcinoma

海报缩略图:整合克隆和单细胞分析揭示早期子宫内膜样子宫内膜癌中祖细胞驱动的肿瘤多样化
编号 7513 展板 15 时间 4/22 09:00–12:00 区域 Section 31 主讲 Suguru Miyata, MD
分会场 Tumor Heterogeneity
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Suguru Miyata1, Hiroshi Yoshida2, Toyoyuki Hanazawa3, Masahito Kawazu4

1Chiba Cancer Center, Chiba, Japan,2Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan,3Chiba University, Chiba, Japan,4Chiba Cancer Center Research Institute, Chiba-shi, Japan

摘要 Abstract

中文摘要
背景与目的 正常子宫内膜经历周期性再生并常含有体细胞突变,然而子宫内膜样子宫内膜癌(EEC)发生的最早步骤仍未得到明确界定。尽管肿瘤异质性源自基因组演化和上皮细胞状态多样性两个方面,但这两个轴在早期肿瘤发生过程中如何相互作用尚未得到充分理解。为解决这一问题,我们聚焦于早期EEC,进行了一项将克隆结构与细胞状态异质性关联起来的整合分析。 方法 我们对37例早期EEC患者的子宫样本进行了多区域全外显子测序(WES),以绘制肿瘤克隆的解剖学分布。涵盖POLE突变型、微卫星不稳定性高和拷贝数低亚型的代表性病例接受了单细胞RNA测序,以表征上皮分化状态并重建谱系关系。利用WES鉴定的体细胞突变以单细胞分辨率推断克隆结构。建立患者来源类器官以功能性评估不同的祖细胞样肿瘤细胞群。 结果 单细胞RNA测序揭示了一个上皮分化谱系,范围从成熟的纤毛细胞和分泌细胞到未分化的祖细胞样肿瘤细胞。这些状态的比例不仅在患者间差异很大,在同一子宫内的不同区域间也差异显著。通过将WES衍生的突变与单细胞图谱整合,我们表明单个肿瘤克隆同时含有祖细胞样细胞和分化细胞,重现了与正常子宫内膜相似的分级上皮组织结构。 亚克隆群在上皮组成和增殖活性上存在显著差异,表明克隆特异性基因组改变影响细胞状态输出。值得注意的是,我们鉴定出两种在转录和功能上不同的祖细胞样肿瘤细胞类型,提示早期肿瘤演化中存在多条分化途径。 结论 早期EEC在遗传和细胞层面表现出协调的异质性。发现两种祖细胞样肿瘤细胞群为驱动早期肿瘤多样化的平行分化程序提供了证据。通过将由遗传改变驱动的克隆演化与单细胞表型整合,本研究完善了当前的EEC分类框架(如ProMisE),并为早期子宫内膜癌的起源、增殖和治疗脆弱点提供了新的生物学见解。
查看英文原文 English abstract
Background and Objectives The normal endometrium undergoes cyclical regeneration and frequently contains somatic mutations, yet the earliest steps of endometrioid endometrial carcinoma (EEC) development remain poorly defined. Although tumor heterogeneity arises from both genomic evolution and diversity in epithelial cell states, how these two axes interact during early tumorigenesis is not well understood. To address this question, we focused on early-stage EEC and performed an integrative analysis linking clonal architecture with cell-state heterogeneity. Methods We performed multi-region whole-exome sequencing (WES) of uterine samples from 37 patients with early-stage EEC to map the anatomical distribution of tumor clones. Representative cases covering POLE-mutated, microsatellite instability-high, and copy-number-low subtypes underwent single-cell RNA sequencing to characterize epithelial differentiation states and reconstruct lineage relationships. Somatic mutations identified by WES were used to infer clonal structures at single-cell resolution. Patient-derived organoids were established to functionally evaluate distinct progenitor-like tumor populations. Results Single-cell RNA sequencing revealed a spectrum of epithelial differentiation, ranging from mature ciliated and secretory cells to undifferentiated progenitor-like tumor cells. The proportions of these states varied widely not only between patients but also across regions within the same uterus. By integrating WES-derived mutations with single-cell profiles, we showed that individual tumor clones contained both progenitor-like and differentiated cells, recapitulating a hierarchical epithelial organization reminiscent of the normal endometrium. Subclonal populations differed markedly in epithelial composition and proliferative activity, indicating that clone-specific genomic alterations influence cell-state output. Notably, we identified two transcriptionally and functionally distinct progenitor-like tumor cell types, suggesting multiple differentiation routes in early tumor evolution. Conclusions Early-stage EEC exhibits coordinated heterogeneity at genetic and cellular levels. The discovery of two progenitor-like tumor populations provides evidence for parallel differentiation programs that drive early tumor diversification. By integrating clonal evolution driven by genetic alterations with single-cell phenotypes, this study refines current EEC classification frameworks such as ProMisE and offers new biological insights into the origins, propagation, and therapeutic vulnerabilities of early-stage endometrial cancer.
利益披露 Disclosure
S. Miyata, None.. M. Kawazu, None.

← 返回 AACR 2026 检索